# iNO300 Therapy in Critically Ill Patients With Pneumonia

> **NCT06950294** · EARLY_PHASE1 · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 34 (estimated)

## Conditions studied

- Critical Illness
- Pneumonia

## Interventions

- **DRUG:** High dose inhaled nitric oxide
- **OTHER:** Sham treatment
- **OTHER:** standard therapy

## Key facts

- **NCT ID:** NCT06950294
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-23
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06950294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06950294, "iNO300 Therapy in Critically Ill Patients With Pneumonia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06950294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*